TAG:
care contracts
Unilab, DIANON Systems, UroCor Report 1998 Financial Results
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
OPTIMISM REIGNS at California-based Unilab Corporation. Revenues are up, operating profits are increasing, and company officials are now talking about growth plans. For 1998, Unilab generated revenues of $217.4 million, compared to $214.0 million in 1997. …
Movers & Shakers For ’99 Demonstrate Leadership
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
EACH YEAR IT BECOMES more difficult to make final selections for our annual Movers & Shakers awards. The reason is simple. Today there are more examples of leadership in the laboratory than when we first started these selections three years ago. This is a good omen. It means that the crucible of…
Sales & Marketing Is Critical To Success Of Labs & Pathologists
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
CEO SUMMARY: Careful study of the most successful lab oratories operating today reveals a common characteristic: the effective use of sale s and marketing methods to boost specimen volume, revenue, and operating profits. This is true whether it’s a hospital lab outreach program, a comme…
Top-Performing Labs at Executive War College
By Robert Michel | From the Volume VI No. 2 – February 1, 1999 Issue
CEO SUMMARY: Once again, Executive War College time approaches. Scheduled for May 11-12, 1999 at the New Orleans Sheraton, this year’s roster of innovative laboratories promises to provide valuable insight about winning strategies. An expanded program offers a lab industry first: a know…
PPM Giant MedPartners Exits Doctor Management
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
THIRD IN A SERIES WHAT DOES IT MEAN WHEN the largest companies in a multibillion dollar industry announce that they will “get out” of that business? That is the question which must be answered after MedPartners, Inc. joined PhyMatrix Corp. in p…
PathSOURCE Is Newest Pathology Consolidator
By Robert Michel | From the Volume V No. 15 – November 9, 1998 Issue
CEO SUMMARY: Based in New York, PathSOURCE becomes the newest pathology network and services company to hit the market. PathSOURCE’s organizers want to link “best in class” dermatopathologists and academic pathology subspecialists to compete for outreach pathology specimens. PathSOU…
SmithKline’s Strategies Now Delivering Benefits
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
CEO SUMMARY: Business strategy does make a difference. However, it sometimes takes years to appreciate the wisdom of choosing one strategy over another. In the case of SmithKline Beecham’s lab division, the decision to become sole-source provider to the nation’s largest HMOs may event…
Washington State’s PacLab Network Is A Regional Winner
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
CEO SUMMARY: As a regional laboratory network, PacLab is unusual in one respect: participating hospital laboratories did not meet endlessly to talk about what they should do. Instead, action was the operative word for these network organizers. Since becoming operational in 1996, their bia…
Pathology PPMs Unlike Most Other PPM Firms
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
PHYSICIAN PRACTICE MANAGEMENT (PPM) companies have arrived at pathology’s doorstep. For better or worse, a new era is pushing its way into the pathology profession. In the first installment of this exclusive DARK REPORT series, we exposed the rotten secret behind the …
Premier Executive John Biggers Discusses Reasons For Laboratory Initiative
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Because of Premier’s influence with 1,700 of the nation’s 5,000 hospitals, laboratory administrators and executives should realize that this strategic services alliance between Premier and Quest Diagnostics Incorporated will change traditional laboratory practices, regard…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized